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Thorough studies of the nature of the group specific A  substance have 
been carried out during recent years.  Several observations seem to indicate 
that  the  A  substance  occurring in  material from human  beings may be 
complex  in  nature.  Following  investigations  of  Brahn  and  Schiff  (1), 
Freudenberg, Eichel, and Dirscherl (2), Landsteiner (3)  first isolated an A 
specific carbohydrate-like substance from horse saliva in 1932.  Since that 
time, the chemical composition of the A specific substance has been investi- 
gated  by  Landsteiner  (4),  Landsteiner  and  Chase  (5),  Landsteiner  and 
Harte  (6),  Meyer, Smyth, and Palmer  (7),  Goebel  (8),  Freudenberg and 
Westphal  (9), and several others.  The study of the A  substance is facili- 
tated by its occurrence in relatively large amounts in commercial prepara- 
tions such as pepsin  and peptone. 
No  data  are  available  as yet as  to  the nature of the group  specific B 
substance.  After  several  unsuccessful  attempts  to  isolate  B  substance 
from  blood  and  various  other  sources,  we  finally  succeeded in  isolating 
it  from stomach juice of subjects belonging to group B,  which has been 
shown to be rich in group specific substances.  The isolation of a  carbo- 
hydrate-like  substance  possessing  B  properties  was  carried  out  by  the 
following technique which is essentially the same as that used by Goebel 
(8) for the isolation of the A substance from commercial peptone. 
EXPERI~ClENTAL 
ii0 CC. of gastric  juice  from two patients  belonging to group B  were 
obtained.  This was centrifuged and the supernatant fluid was heated for 
5 minutes in a  boiling water bath.  After cooling, the material was again 
centrifuged and  14 gm. of anhydrous sodium acetate was dissolved in the 
clear supernatant fluid.  275  cc. of alcohol were added and  the resulting 
precipitate  was  centrifuged the  following  day.  10  cc.  of  normal  saline 
solution were added to this precipitate, and after several hours the mixture 
was  again  centrifuged and  the  undissolved  residue  discarded.  1.4  gm. 
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anhydrous sodium acetate followed by 25 cc. of alcohol were added to the 
supernatant fluid and the mixture was allowed to  stand overnight.  The 
precipitate obtained was treated again with normal saline, sodium acetate, 
and  alcohol.  The precipitate  was  taken  up  in  10  cc.  of water and  the 
insoluble material discarded.  This solution was adjusted to  a  pH equal 
to  4.8  using  sodium  acetate  and  acetic acid.  The  deproteinization was 
performed with  chloroform and  butyl  alcohol according  to  Sevag's pro- 
cedure.  After separation  the deproteinized solution was dialyzed for 48 
hours  against  successive  changes of  distilled  water.  The  dialyzate was 
subsequently evaporated in vacuo to a volume of 3.5  cc.  The active frac- 
tion was obtained as a  precipitate after adding this solution to  35  cc. of 
acetone.  The precipitate was collected in a  centrifuge tube, washed with 
acetone, and dried over calcium chloride in vacuo.  The total yield obtained 
was  13.5  mg. 
The material contained 1.5 to 1.6 per cent nitrogen on an ash-free basis 
(ash  5.9  per  cent)  and on  hydrolysis gave a  reduction corresponding to 
75 per cent glucose.  A 1 per cent solution gave a strongly positive Molisch 
test.  No  precipitation  was  obtained  with  trichloracetic  acid  or  sulfo- 
salicylic acid. 
Serologic  A ctivity of Material Containing B  Substance and of the 
Carbohydrate-Like B  Substance Itself 
In order to determine the amount of B substance present in our material, 
the  method of inhibition  of isoagglutination  was  used.  The  first  table 
shows  an  experiment in  which  the  amounts  of  B  substance  present  in 
saliva and gastric juice were determined. 
Decreasing amounts of saliva and gastric juice respectively (total volume 
0.2  cc.)  were incubated for  15 minutes at room temperature with 0.2  cc. 
inactivated human serum belonging to group A  (dilution  1:3).  To  this 
was added 0.2 cc. of a  1 per cent suspension of human blood cells belonging 
to group B.  Agglutination was recorded following centrifugation of the 
tubes. 
Table I  shows that the B  contents of saliva and gastric juice are prac- 
tically identical.  Dilutions up to  1:2000 completely inhibit agglutination 
of human cells belonging to group B  by A serum because of the preceding 
combination of the isoagglutinin anti-B  with  the B  substance present in 
saliva and gastric juice respectively.  It should be added that this inhibition 
is  specific in nature inasmuch  as  specimens of gastric juice belonging to 
group A and group O are without inhibitory effect in this type of experiment. 
The activity of the group specific substance B as isolated from the above 
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Decreasing  amounts of a  1:1000  stock  solution of B  specific substance 
(total volume 0.2  cc.) were  incubated for 15 minutes at room temperature 
with 0.1  cc. of undiluted  inactivated human serum belonging to group A. 
To this was added 0.2  cc. of a  1 per cent suspension of human blood cells 
belonging to group B.  Agglutination was recorded following centrifugation 
of  the  tubes. 
As  can  be  seen  from Table  II,  a  1:2000  dilution  of the  1:1000  stock 
solution of the B  substance  completely inhibits isoagglutination of human 
cells belonging to group B  by serum of group A.  The inhibitory power of 
TABLE I 
Agglutination of Human B Cells by Serum of Group A  after Treatment of the Latter with 
Increasing Dilutions of Saliva and Gastric Juice of Group B Respectively 
Dilution of saliva and gastric juice  Saliva  Gastric juice 
respectively 
(1)  1:10 
(2)  1:30 
(3)  1:90 
(4)  1:270 
(5)  1:81o 
(6)  1:2,430 
(7)  1:7,290 
(8)  1:21,870 
(9)  1:65,610 
(10)  1:196,830 
(11)  1:590,490 
(12)  0 
q 
+ 
+ 
+ 
++ 
+++ 
+++ 
-4- 
+ 
+ 
++ 
+++ 
+++ 
-  =  no agglutination. 
=  faint agglutination. 
+  =  slight agglutination. 
+ +  =  marked agglutination. 
-4- -4- +  =  strong agglutination. 
+ + + +  =  very strong agglutination. 
the  isolated  group  specific substance  B  is  marked,  for  even  in  dilutions 
of one  in  several millions  a  partial  inhibition  of isoagglutination  can  be 
demonstrated.  If  the  potency  of  the  isolated  B  substance  is compared 
with that of the untreated  stomach  juice specimens,  the  concentration of 
B  substance in the original stomach juices examined can be roughly esti- 
mated as one in a  thousand. 
In  order  to  compare  approximately  the  potency  of  the  B  substance 
with that of the A  substance) several sera of group A  and group B  respec- 
tively were examined.  Two sera of about the same strength were selected 
for Experiment III. 
1  The A substance was  prepared  from Difco's  neopeptone according to  Goebel's 
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Decreasing amounts of group specific  A substance (total  volume 0.2 cc.) 
were pipetted into  row i, while exactly the same dilutions  of group specific 
TABLE  II 
Agglutination  of Human B  Cells by Serum of Group A  after Treatment of the Latter with 
Increasing Dilutions of B Specific Substance 
1:1,000  dilution of B specific substance  Degree of agglutination 
(1)  1:10 
(2)  1: 30 
(3)  1:90 
(4)  1: 270 
(s)  1:81o 
(6)  1: 2,430 
(7)  1: 7,290 
(8)  1: 21,870 
(9)  1:65,610 
(10)  1:196,830 
(11)  1:590,490 
(12)  0 
m 
m 
N 
+ 
+ 
+ 
+ 
++ 
+++ 
TABLE  III 
Agglutination  of Human A  and B  Cells by Human Serum of Group A  and Group B 
Respectively after Treatment of the Latter with the Isolated Group Specific Substances 
1:1,000  dilution of group specific  A substance and serum group B  B  substance and serum group A  +  + 
substances  group A cell suspension  group B cell suspension 
(1)  1:10 
(2)  1: 30 
(3)  1:90 
(4)  1:270 
(5)  1: 810 
(6)  1:2,430 
(7)  1: 7,290 
(8)  1: 21,870 
(9)  1:65,610 
(10)  1:196,830 
(11)  1:590,490 
(12)  0 
m 
+ 
+ 
++ 
++ 
+++ 
+++ 
++-F 
++++ 
+ 
+ 
+ 
++ 
+++ 
+++ 
+++ 
++++ 
B  substance  were pipetted into  row 2.  0.2  cc.  of a  1:3  diluted  serum of 
group B  was added to row 1, and 0.2 cc. of 1:3 diluted serum of group A to 
row  2.  After  standing  for  15  minutes  at  room  temperature,  0.2  cc.  of a 
1 per cent suspension of human blood cells belonging to group A was added 
to row 1, and 0.2 cc. of a  1 per cent suspension of human blood cells belong- ERNEST WlTEBSK¥  AND  NIELS  C.  KLENDSHOJ  667 
ing to group B to row 2.  After standing for 5 minutes at room temperature, 
the tubes were centrifuged.  Agglutination was recorded following centrifu- 
gation of the tubes. 
These results indicate that the isolated group specific substances A and 
B behave almost alike as far as their capacity to inhibit isoagglutination is 
concerned.  They are  both  very potent.  Because of  the  small  amount 
of  B  substance  obtained  so  far,  definite  conclusions  as  to  its  chemical 
composition must be deferred until further material is available. 
CONCLUSION 
The isolation of group specific B  substance from human stomach juice 
is  described.  The  substance  is  carbohydrate-like  in  nature  and  is  as 
potent as the carbohydrate-like substance group A isolated from commercial 
pepsin and peptone respectively. 
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